Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP) (Q35724113)

9 August 2017

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP) (English)

1 reference

randomized controlled trial

9 August 2017

0 references

1 reference

1

1 reference

9 August 2017

William Timothy Garvey

3

object named as

William Timothy Garvey

1 reference

9 August 2017

5

Michael L Schwiers

1 reference

9 August 2017

8

Barbara Troupin

1 reference

9 August 2017

Kishore M Gadde

2

1 reference

9 August 2017

Craig A Peterson

4

1 reference

9 August 2017

Thomas Najarian

6

1 reference

9 August 2017

Peter Y Tam

7

1 reference

9 August 2017

Wesley W Day

9

1 reference

9 August 2017

3 November 2011

1 reference

9 August 2017

1 reference

9 August 2017

20

1 reference

9 August 2017

330-342

1 reference

9 August 2017

2

1 reference

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Multicenter, placebo-controlled trial of lorcaserin for weight management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Prevalence and trends in obesity among US adults, 1999-2008

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Drugs associated with more suicidal ideations are also associated with more suicide attempts

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Appetite suppressants, cardiac valve disease and combination pharmacotherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Bariatric surgery: a systematic review and meta-analysis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Effects of tyrosine, phentermine, caffeine D-amphetamine, and placebo on cognitive and motor performance deficits during sleep deprivation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Influence of topiramate in the regulation of energy balance

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Statistical considerations in the intent-to-treat principle

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Baseline observation carry forward: reasoning, properties, and practical issues

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Predictors of Weight Loss in Adults with Topiramate‐Treated Epilepsy

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Impact of weight loss on the metabolic syndrome

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

23 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3270297

The effects of topiramate and sex hormones on energy balance of male and female rats

7 December 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.330

Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.330

The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.330

Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.330

Evaluation of Phentermine and Fenfluramine, Alone and in Combination, in Normal, Healthy Volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.330

Obesity research--limitations of methods, measurements, and medications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.330

UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22051941

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Beneficial health effects of modest weight loss

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22051941

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/OBY.2011.330

1 reference

9 August 2017

1 reference

9 August 2017

1 reference